Target Name: ZNF34
NCBI ID: G80778
Review Report on ZNF34 Target / Biomarker Content of Review Report on ZNF34 Target / Biomarker
ZNF34
Other Name(s): Zinc finger protein 34, transcript variant 1 | Zinc finger protein KOX32 | Zinc finger protein 34 | KOX32 | ZNF34_HUMAN | Zinc finger protein 34 (isoform 1) | zinc finger protein KOX32 | ZNF34 variant 1 | zinc finger protein 34 | zinc finger protein 34 (KOX 32) | Zinc finger protein 34 (KOX 32)

ZNF34: A Potential Drug Or Biomarker for Various Diseases

ZNF34, also known as Zinc finger protein 34, is a gene that encodes a protein known for its role in various cellular processes. The ZNF34 protein is a key component of the ZNF3 complex, a protein-protein interaction that is involved in a wide range of cellular processes, including cell growth, differentiation, and survival. ZNF34 has also been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. As a result, ZNF34 has become an attractive target for researchers to explore as a potential drug or biomarker.

The ZNF3 complex is a protein-protein interaction that is formed by the interaction of the ZNF2 protein and ZNF34. ZNF2 is a transcription factor that has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and gene expression. ZNF34, on the other hand, is a protein that is known to interact with ZNF2 and play a role in the regulation of these processes.

One of the key functions of the ZNF34 protein is its role in the regulation of cell growth. The ZNF34 protein has been shown to play a negative role in the regulation of cell growth by inhibiting the activity of the S6 kinase, a protein that is involved in the regulation of cell cycle progression. This means that when S6 kinase is activated, it can cause cell growth to increase, which can lead to the development of cancer. By inhibiting the activity of S6 kinase, the ZNF34 protein has been shown to have the potential to be a useful drug or biomarker for the treatment of cancer.

Another function of the ZNF34 protein is its role in the regulation of differentiation. The ZNF34 protein has been shown to play a key role in the regulation of cellular differentiation by interacting with the transcription factor, NF-kappa-B. This means that when NF-kappa-B is activated, it can cause the cells to differentiate into specific types of cells, which is important for the development of tissues and organs. By interacting with NF-kappa-B, the ZNF34 protein has been shown to have the potential to be a useful drug or biomarker for the treatment of neurodegenerative diseases.

In addition to its role in cell growth and differentiation, the ZNF34 protein has also been implicated in a number of other diseases, including cancer and developmental disorders. For example, studies have shown that the ZNF34 gene is often mutated in various types of cancer, which can lead to the development of these diseases. Additionally, the ZNF34 protein has also been implicated in the development of developmental disorders, such as Down syndrome.

Given the ZNF34 protein's involvement in a wide range of cellular processes, it is not surprising that it has become an attractive target for researchers to explore as a potential drug or biomarker. Many studies have shown that the ZNF34 protein has the potential to be a useful drug or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that the ZNF34 protein has the potential to be a useful drug for the treatment of cancer by inhibiting the activity of S6 kinase. Additionally, the ZNF34 protein has also been shown to have the potential to be a useful biomarker for the diagnosis and prognosis of neurodegenerative diseases.

In conclusion, ZNF34 is a protein that has the potential to be a drug target or biomarker for a wide range of diseases. Its role in the regulation of cell growth, differentiation, and various other cellular processes makes it an attractive target for researchers to explore. Further studies are needed to determine the full potential

Protein Name: Zinc Finger Protein 34

Functions: May be involved in transcriptional regulation

The "ZNF34 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF34 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496